Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
580.12B
Market cap580.12B
Price-Earnings ratio
27.64
Price-Earnings ratio27.64
Dividend yield
2.19%
Dividend yield2.19%
Average volume
9.39M
Average volume9.39M
High today
$243.04
High today$243.04
Low today
$238.72
Low today$238.72
Open price
$240.37
Open price$240.37
Volume
8.14M
Volume8.14M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$150.73
52 Week low$150.73

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $241.00. The company's market cap stands at 580.12B, with a P/E ratio of 27.64 and a dividend yield of 2.19%.

On 2026-06-24, Johnson & Johnson(JNJ) stock traded between a low of $238.72 and a high of $243.04. Shares are currently priced at $241.00, which is +1.0% above the low and -0.8% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 8.14M, against a daily average of 9.39M.

During the past year, Johnson & Johnson(JNJ) stock moved between $150.73 at its lowest and $251.71 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $150.73 at its lowest and $251.71 at its peak.

JNJ News

24/7 Wall St. 3h
SNPD ETF Targets Next Dividend Aristocrats With 10-year Growth Screen

SNPD ETF Targets Next Dividend Aristocrats With 10-year Growth Screen By John Seetoo Published Jun 24, 4:02PM EDT Quick Read SNPD targets 10-year dividend gro...

SNPD ETF Targets Next Dividend Aristocrats With 10-year Growth Screen
24/7 Wall St. 4h
Equal Weighted Dividends Across 54 Stocks Deliver 24.7% Returns and Growing Payouts

Equal Weighted Dividends Across 54 Stocks Deliver 24.7% Returns and Growing Payouts By John Seetoo Published Jun 24, 3:00PM EDT Quick Read SPDV equal-weights...

Equal Weighted Dividends Across 54 Stocks Deliver 24.7% Returns and Growing Payouts
Reuters 8h
Johnson expects Trump to sign affordable housing bill within 10 days - Reuters

...

Johnson expects Trump to sign affordable housing bill within 10 days - Reuters

Analyst ratings

68%

of 25 ratings
Buy
68%
Hold
28%
Sell
4%

More JNJ News

24/7 Wall St. 11h
After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching By Trey Thoelcke Published Jun 24, 7:55AM EDT Quick Read Legend Biotech (LEGN) gen...

After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching
Simply Wall St 1d
How Investors Are Reacting To Johnson & Johnson Oncology And Rare-Disease Trial Wins

In mid-June 2026, Johnson & Johnson reported strong Phase 3 MonumenTAL-3 data for TALVEY in relapsed/refractory multiple myeloma and positive Phase 2/3 ENERGY r...

How Investors Are Reacting To Johnson & Johnson Oncology And Rare-Disease Trial Wins
24/7 Wall St. 2d
This Is the Dividend Portfolio That Pays Off Your Kid's Student Loans

This Is the Dividend Portfolio That Pays Off Your Kid’s Student Loans By Drew Wood Published Jun 23, 6:25AM EDT Quick Read Covering a $600 monthly student loa...

This Is the Dividend Portfolio That Pays Off Your Kid's Student Loans
TipRanks 2d
Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

24/7 Wall St. 2d
The Portfolio That Quietly Pays For Your Gasoline Forever

The Portfolio That Quietly Pays For Your Gasoline Forever By Drew Wood Published Jun 22, 9:09AM EDT Quick Read Covering a $3,000 annual gas bill requires $85,...

The Portfolio That Quietly Pays For Your Gasoline Forever
24/7 Wall St. 3d
Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income By Vandita Jadeja Published Jun 21, 11:30AM EDT Quick Read 500 shares each of PFE and...

Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income
24/7 Wall St. 3d
Pharma Momentum Fuels Johnson & Johnson's Path to Double-Digit Upside

Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside By Vandita Jadeja Published Jun 21, 10:30AM EDT Quick Read JNJ earns a BUY rating with a...

Pharma Momentum Fuels Johnson & Johnson's Path to Double-Digit Upside

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.